Biocompatibility of trillium biopassive surface-coated oxygenator during cardiopulmonary bypass

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 15, Issue 5, 2001, Pages 539-541

  Stammers, Alfred H ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETICONE; MACROGOL; PHOSPHORYLCHOLINE; POLYCAPROLACTONE;

BIOCOMPATIBILITY; CARDIOPULMONARY BYPASS; DEVICE; EDITORIAL; HEART PERFUSION; HEART SURGERY; OXYGENATOR; PRIORITY JOURNAL; ROBOTICS; SURGICAL TECHNIQUE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

EID: 0034783976     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/jcan.2001.26521     Document Type: Article

References (19)

1. Complement activation during cardiopulmonary bypass: Evidence for generation of C3a and C5a anaphylatoxins
2. Acute alterations of body composition after open intracardiac operations
3. Pulmonary injury secondary to extracorporeal circulation: An ultrastructural study
4. Etiology, incidence, and prognosis of renal failure following cardiac operations: Results of a prospective analysis of 500 consecutive patients
5. Perfusion accident survey
6. A retrospective study on perfusion incidents and safety devices
7. Longitudinal assessment of neurocognitive function after coronary artery bypass surgery
8. Central nervous system complications of cardiac surgery
9. Reduced complement activation and improved postoperative performance after cardiopulmonary bypass with heparin coated circuits
10. Heparin surface bonding on colloidal graphite surface
11. Issues of biocompatibility: Heparin-coated extracorporeal circuit
12. Heparin-bonded circuits: Clinical outcomes and costs
13. Quantitative evaluation of heparin coated versus non-heparin-coated bypass circuits during cardiopulmonary bypass
14. Completely heparinized cardiopulmonary bypass and reduced systemic heparin: Clinical and hemostatic effects
15. Risk and benefit of low systemic heparinization during open heart surgery
16. Heparin-bonded circuits with a reduced anticoagulation protocol in primary CABG: A prospective, randomized study
17. Comparison of two heparin-coated extracorporeal circuits with reduced systemic anticoagulation in routine coronary artery bypass operations
18. Trillium biopassive surface: A new biocompatible treatment for extracorporeal circulation circuits
19. Effect of trillium biopassive surface coating of the oxygenator on platelet count drop during cardiopulmonary bypass